Currently, NAFLD lacks efficacious targeted pharmacological interventions, and therefore, treatment strategies primarily involve modifying one’s dietary and lifestyle habits, protecting liver function, reducing cholesterol levels, and enhancing insulin sensitivity [20,21]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.